Recall: D-0836-2020

Class II - Potentially Harmful

Class IIClassification

2020-01-27Initiated

TerminatedStatus

Teva Pharmaceuticals USAFirm

Product

Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01

Reason

CGMP deviations: Product bottle may be absent of desiccant.

Distribution

USA Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.